Top Page
Oneview Healthcare Chess Depository Interests repr 1
(OTC:ONE)
Oneview Healthcare Chess Depository Interests repr 1 (ONE) vs. iShares MSCI Australia ETF (EWA)
Oneview Healthcare Chess Depository Interests repr 1 Business Overview & Revenue Model
Oneview Healthcare Chess Depository Interests repr 1 Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.57M | 9.89M | 9.40M | 8.92M | 9.73M | 7.10M |
| Gross Profit | 7.11M | 6.67M | 6.16M | 5.35M | 5.31M | 4.72M |
| EBITDA | -12.01M | -11.26M | -7.88M | -12.09M | -8.01M | -7.44M |
| Net Income | -13.23M | -10.84M | -8.93M | -10.87M | -8.19M | -9.45M |
Balance Sheet | ||||||
| Total Assets | 16.15M | 25.96M | 21.92M | 12.75M | 21.09M | 14.25M |
| Cash, Cash Equivalents and Short-Term Investments | 8.19M | 13.83M | 11.55M | 6.41M | 15.18M | 6.80M |
| Total Debt | 979.00K | 1.15M | 935.32K | 543.01K | 1.20M | 1.51M |
| Total Liabilities | 8.65M | 12.71M | 12.78M | 10.50M | 11.19M | 10.18M |
| Stockholders Equity | 7.50M | 13.25M | 9.14M | 2.26M | 9.90M | 4.07M |
Cash Flow | ||||||
| Free Cash Flow | -10.11M | -10.52M | -7.79M | -10.24M | -4.09M | -7.94M |
| Operating Cash Flow | -10.06M | -10.47M | -7.26M | -10.20M | -4.03M | -7.69M |
| Investing Cash Flow | -142.66K | -459.78K | -521.38K | -44.52K | -65.26K | -249.35K |
| Financing Cash Flow | 12.99M | 13.14M | 13.04M | -100.11K | 12.22M | 5.07M |
Oneview Healthcare Chess Depository Interests repr 1 Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1 Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | AU$379.29M | 24.15 | 22.84% | 0.93% | 21.47% | 89.09% | |
64 Neutral | AU$126.24M | 78.33 | 1.89% | ― | 10.06% | ― | |
55 Neutral | AU$74.13M | -8.12 | -8647.54% | ― | 25.98% | 22.10% | |
54 Neutral | AU$282.44M | ― | ― | ― | 21.56% | -24.08% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$58.12M | -9.39 | -13.83% | ― | 3.61% | -17.03% | |
46 Neutral | AU$122.18M | ― | -12.35% | ― | 15.99% | 22.05% |
Oneview Healthcare Chess Depository Interests repr 1 Corporate Events
Oneview Healthcare PLC announced a change in the director’s interest as Darragh Lyons acquired 3,000,000 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs). This change reflects the company’s ongoing commitment to aligning executive interests with shareholder value, as approved by shareholders at the recent AGM. The acquisition of these CDIs suggests confidence in the company’s strategic direction and potential growth, which may positively impact stakeholder perceptions and market positioning.
Oneview Healthcare PLC announced a change in the director’s interest, specifically regarding Barbara Nelson’s holdings. The change involved the acquisition of 327,868 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs) under the company’s NED & Consultant RSU Plan, as approved by shareholders. This adjustment reflects the company’s ongoing efforts to align director incentives with shareholder interests, potentially impacting the company’s governance and stakeholder confidence.
Oneview Healthcare PLC has announced the appointment of Michael Dowling as a director, effective from December 2, 2025. The initial director’s interest notice reveals that Mr. Dowling currently holds no securities or contracts related to the company, indicating a fresh start in his role without prior financial entanglements.
Oneview Healthcare PLC announced the issuance of 3,983,604 restricted share units under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions, reflecting the company’s strategy to incentivize and retain key personnel, potentially impacting its operational efficiency and market positioning.
Oneview Healthcare PLC has amended its constitution to include all special resolutions passed up to December 2025, reflecting its strategic focus on expanding its business operations and enhancing its property value. This move could potentially strengthen its market position and offer new opportunities for collaboration and growth within its industry.
Oneview Healthcare has experienced significant growth in 2025, marked by an increase in customer base and product innovation. The company maintained a strong financial position with disciplined cost control and a healthy cash reserve. Notable achievements include the addition of new clients such as Willis-Knighton Health System and White Plains Hospital, and the expansion of existing client partnerships, which contributed to a 20% growth in annual recurring revenue. The launch of Ovie, an AI-powered care assistant, highlights Oneview’s commitment to innovation, aiming to improve nurse efficiency and patient empowerment. The partnership with Baxter has also bolstered Oneview’s market presence, leading to a record sales pipeline.
Oneview Healthcare Plc held its Annual General Meeting on December 1, 2025, in Dublin, where all resolutions were passed, including the reappointment of directors and the approval of remuneration and stock awards. The meeting’s outcomes demonstrate strong shareholder support and are expected to positively impact the company’s governance and strategic initiatives.
Oneview Healthcare PLC announced a change in the director’s interest, specifically regarding Nashina Asaria Bacorn. On November 15, 2025, Bacorn acquired 156,250 CDIs upon the vesting of Restricted Share Units (RSUs) and sold 78,125 CDIs to settle mandatory Irish payroll taxes. This transaction reflects a strategic move to manage tax obligations while increasing Bacorn’s holdings to 762,359 CDIs, potentially signaling confidence in the company’s future performance.
Oneview Healthcare PLC announced a change in the director’s interest, with Mark Cullen acquiring 234,375 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs). To settle mandatory Irish payroll taxes, 117,188 CDIs were sold, resulting in a net increase in Cullen’s holdings. This change reflects the company’s ongoing commitment to aligning executive interests with shareholder value, potentially impacting stakeholder perceptions and market positioning.
Oneview Healthcare PLC announced a change in the director’s interest, with Joseph Rooney acquiring 234,375 CDIs upon the vesting of Restricted Share Units (RSUs) and disposing of 117,188 CDIs to settle mandatory Irish payroll taxes. This adjustment in director’s holdings reflects routine administrative changes and does not indicate any significant strategic shift for the company.
Oneview Healthcare PLC announced a change in the director’s interest, with Director Darragh Lyons acquiring 150,000 CDIs upon the vesting of Restricted Share Units (RSUs) and disposing of 82,500 CDIs to settle mandatory Irish payroll income taxes. This transaction reflects the company’s ongoing management of executive compensation and tax obligations, which could impact its financial reporting and stakeholder perceptions.
Oneview Healthcare PLC announced a change in the director’s interest notice, involving Barbara Nelson. On November 15, 2025, Nelson acquired 312,500 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs) and sold 156,250 CDIs to settle mandatory Irish payroll taxes. This transaction reflects internal adjustments in director holdings, with potential implications for the company’s governance and financial reporting.
Oneview Healthcare PLC announced the application for the quotation of 1,891,030 CHESS Depositary Interests on the ASX. This move is part of the company’s strategy to enhance its market presence and provide liquidity to its securities, potentially benefiting stakeholders by increasing the accessibility and transferability of its shares.
Oneview Healthcare has appointed Michael J. Dowling, CEO Emeritus of Northwell Health, as a Non-Executive Director to its Board, effective December 2, 2025. Dowling’s extensive experience in healthcare innovation and leadership is expected to provide Oneview with strategic insights as it continues to expand its digital engagement platform globally. His appointment aligns with Oneview’s mission to transform patient experiences and enhance engagement through technology, promising to bolster the company’s growth and success in the healthcare industry.
Oneview Healthcare has identified an unintentional non-compliance with ASX Listing Rule 10.11 regarding the issuance of CHESS Depositary Interests (CDIs) to a substantial holder without necessary approvals. This oversight occurred during capital raisings and has led to a holding lock on the CDIs, pending approval from CDI holders at the upcoming AGM. Oneview is actively reviewing its compliance systems to prevent future occurrences and is seeking resolution approval to release the holding lock, which will impact the company’s operations and stakeholder relations.
Oneview Healthcare reported a cash balance of €5.9 million at the end of Q3 2025, with a net cash outflow of €2.2 million for the quarter. The outflow was impacted by a delayed customer renewal fee, but the company saw a subsequent cash inflow in October. Operationally, Oneview maintained strong momentum, adding a new customer, Kennedy Krieger, and progressing with deployments at existing sites. The company is on track to exceed 15,000 live endpoints by year-end and is in advanced contract discussions with potential new customers, indicating continued growth and expansion in the healthcare technology sector.
Oneview Healthcare PLC has announced the application for the quotation of 905,619 CHESS Depositary Interests on the Australian Securities Exchange. This move indicates the company’s ongoing efforts to enhance its market presence and provide liquidity options for its stakeholders, potentially impacting its operational capabilities and industry positioning positively.
Oneview Healthcare PLC announced the cessation of 50,000 restricted share units due to unmet conditions, reflecting a lapse in conditional rights. This development may impact the company’s capital structure and investor perception, highlighting challenges in meeting certain operational or strategic conditions.
Oneview Healthcare PLC announced the cessation of 267,900 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.